SKAN Group AGFRA:7VG +2.61%62 Pretax Margin % is 14.24% as of Dec. 2025, which is 47% above its 10-year median of 9.68. GuruFocus rates FRA:7VG with a GF Score™ of 62/100 and a GF Value™ of €90.87 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 814 Medical Devices & Instruments companies, SKAN Group AG ranks better than 58.48% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. SKAN Group AG's Pre-Tax Income for the
six
months ended in Dec. 2025 was €30.3 Mil. SKAN Group AG's Revenue for the
six
months ended in Dec. 2025 was €213.0 Mil. Therefore, SKAN Group AG's pretax margin for the quarter that ended in Dec. 2025 was 14.24%.
The historical rank and industry rank for SKAN Group AG's Pretax Margin % or its related term are showing as below:
FRA:7VG'
s Pretax Margin % Range Over the Past 10 Years
Min: 6.41 Med: 9.68 Max: 12.95
Current: 6.41
FRA:7VG's Pretax Margin % is ranked better than 58.48% of 814
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs FRA:7VG: 6.41
SKAN Group AG (FRA:7VG) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
SKAN Group AG Pretax Margin % Related Terms
SKAN Group AG Pretax Margin % Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7VG vs ISRG, BDX, MDLN: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, SKAN Group AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SKAN Group AG Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where SKAN Group AG's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKAN Group AG (FRA:7VG) has a Pretax Margin % of 14.24% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on SKAN Group AG and its competitors. This is 47% above median its historical median of 9.68. Over the past decade, SKAN Group AG's Pretax Margin % has ranged from 6.41 to 12.95. According to the industry distribution chart, SKAN Group AG ranks #338 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 41.5%.
Is SKAN Group AG's Pretax Margin % too high?
SKAN Group AG's current Pretax Margin % of 14.24% is 47% above median its 10-year median of 9.68. Over the past 10 years, this metric has ranged from a low of 6.41 to a high of 12.95. The Medical Devices & Instruments industry median Pretax Margin % is 2.51. SKAN Group AG's value of 14.24% is 468.5% above this industry median. Based on the distribution chart, SKAN Group AG ranks #338 out of 814 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, SKAN Group AG has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #338 out of 814 companies for Pretax Margin %. This puts SKAN Group AG in the upper half of its industry. The industry median Pretax Margin % is 2.51. SKAN Group AG's value of 14.24% is 468.5% above this benchmark. Historically, SKAN Group AG's own Pretax Margin % has ranged from 6.41 to 12.95 over the past decade. While the company's 10-year median is 9.68 vs. the industry median of 2.51, SKAN Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SKAN Group AG's current Pretax Margin % of 14.24% is 468.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on SKAN Group AG and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current Pretax Margin % is 14.24%, which is 47% above median its own 10-year median of 9.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (FRA:7VG) is currently considered Significantly Undervalued. The stock's GF Value™ is €90.87, compared to a current price of €59.00 — trading 35.1% below its estimated fair value. The current Pretax Margin % is 14.24%, which is 47% above median its 10-year median of 9.68 and 468.5% above the Medical Devices & Instruments industry median of 2.51. SKAN Group AG's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current Pretax Margin % is 14.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (FRA:7VG) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of €59.00 is trading 35.1% below its estimated GF Value™ of €90.87.
GuruFocus considers SKAN Group AG to be Significantly Undervalued.
Key valuation signals for FRA:7VG:
Pretax Margin %: 14.24% (47% above median its 10-year median of 9.68)
GF Value™: €90.87 vs. price of €59.00 (35.1% below fair value)
Industry Position: 468.5% above the Medical Devices & Instruments median (#338 of 814)
No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
62GF Score
Get the complete analysis for FRA:7VG
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7VG has been successfully added to your 
